Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Zak

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
International Journal of Biological Macromolecules|April 29, 2021
Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacyYash Gupta, Dawid Maciorowski, Samantha E Zak, et al.
Nature Immunology|March 10, 2009
Function of C/EBPdelta in a regulatory circuit that discriminates between transient and persistent TLR4-induced signalsVladimir Litvak, Stephen A Ramsey, Alistair G Rust, et al.
The Journal of Infectious Diseases|May 7, 2015
Interferon α/β Receptor-Deficient Mice as a Model for Ebola Virus DiseaseJennifer M Brannan, Jeffery W Froude, Laura I Prugar, et al.
Cell Host & Microbe|February 14, 2020
Longitudinal Human Antibody Repertoire against Complete Viral Proteome from Ebola Virus Survivor Reveals Protective Sites for Vaccine DesignSurender Khurana, Supriya Ravichandran, Megan Hahn, et al.
The Journal of Infectious Diseases|January 12, 2018
Prospective Discrimination of Controllers From Progressors Early After Low-Dose Mycobacterium tuberculosis Infection of Cynomolgus Macaques using Blood RNA SignaturesEthan G Thompson, Smitha Shankar, Hannah P Gideon, et al.
RSC Medicinal Chemistry|November 15, 2021
A novel compound active against SARS-CoV-2 targeting uridylate-specific endoribonuclease (NendoU/NSP15): <i>in silico</i> and <i>in vitro</i> investigationsSumit Kumar, Yash Gupta, Samantha E Zak, et al.
Tuberculosis (Edinburgh, Scotland)|March 22, 2018
Considerations for biomarker-targeted intervention strategies for tuberculosis disease preventionAndrew Fiore-Gartland, Lindsay N Carpp, Kogieleum Naidoo, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2012
Postexposure antibody prophylaxis protects nonhuman primates from filovirus diseaseJohn M Dye, Andrew S Herbert, Ana I Kuehne, et al.
The Journal of Biological Chemistry|March 4, 2018
Design and evaluation of bi- and trispecific antibodies targeting multiple filovirus glycoproteinsElisabeth K Nyakatura, Samantha E Zak, Anna Z Wec, et al.
Mabs|March 14, 2017
Generation and characterization of protective antibodies to Marburg virusJeffrey W Froude, Thibaut Pelat, Sebastian Miethe, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
International Journal of Biological Macromolecules|April 29, 2021
Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacyYash Gupta, Dawid Maciorowski, Samantha E Zak, et al.
Nature Immunology|March 10, 2009
Function of C/EBPdelta in a regulatory circuit that discriminates between transient and persistent TLR4-induced signalsVladimir Litvak, Stephen A Ramsey, Alistair G Rust, et al.
The Journal of Infectious Diseases|May 7, 2015
Interferon α/β Receptor-Deficient Mice as a Model for Ebola Virus DiseaseJennifer M Brannan, Jeffery W Froude, Laura I Prugar, et al.
Cell Host & Microbe|February 14, 2020
Longitudinal Human Antibody Repertoire against Complete Viral Proteome from Ebola Virus Survivor Reveals Protective Sites for Vaccine DesignSurender Khurana, Supriya Ravichandran, Megan Hahn, et al.
The Journal of Infectious Diseases|January 12, 2018
Prospective Discrimination of Controllers From Progressors Early After Low-Dose Mycobacterium tuberculosis Infection of Cynomolgus Macaques using Blood RNA SignaturesEthan G Thompson, Smitha Shankar, Hannah P Gideon, et al.
RSC Medicinal Chemistry|November 15, 2021
A novel compound active against SARS-CoV-2 targeting uridylate-specific endoribonuclease (NendoU/NSP15): <i>in silico</i> and <i>in vitro</i> investigationsSumit Kumar, Yash Gupta, Samantha E Zak, et al.
Tuberculosis (Edinburgh, Scotland)|March 22, 2018
Considerations for biomarker-targeted intervention strategies for tuberculosis disease preventionAndrew Fiore-Gartland, Lindsay N Carpp, Kogieleum Naidoo, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2012
Postexposure antibody prophylaxis protects nonhuman primates from filovirus diseaseJohn M Dye, Andrew S Herbert, Ana I Kuehne, et al.
The Journal of Biological Chemistry|March 4, 2018
Design and evaluation of bi- and trispecific antibodies targeting multiple filovirus glycoproteinsElisabeth K Nyakatura, Samantha E Zak, Anna Z Wec, et al.
Mabs|March 14, 2017
Generation and characterization of protective antibodies to Marburg virusJeffrey W Froude, Thibaut Pelat, Sebastian Miethe, et al.
Pageof 9